Estimating the importance of infection in IBS

American Journal of Gastroenterology

Volumn 98, Issue 2, 2003, Pages 238-241

  Spiller, Robin C ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; CAMPYLOBACTER; CLINICAL FEATURE; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; EDITORIAL; GASTROENTERITIS; HUMAN; INTESTINE FUNCTION; IRRITABLE COLON; PRIORITY JOURNAL; PROGNOSIS; SALMONELLA; SEX DIFFERENCE; SHIGELLA;

EID: 0037282960     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07275.x     Document Type: Editorial

References (30)

1. Chaudary NA, Truelove SC. The irritable colon syndrome. Quart J Med 1962;123:307-22.
2. McKendrick MW, Read NW. Irritable bowel syndrome - Post Salmonella infection. J Infect 1994;29:1-3.
3. Gwee KA, Graham JC, McKendrick MW, et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996;347:150-3.
4. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: Postal survey of patients (see comments). Br Med J 1997;314: 779-82.
5. Neal K, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: A six year follow up study. Gut 2002;51:410-3.
6. Rodriguez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: Cohort study. Br Med J 1999;318:565-6.
7. Thornley JP, Brough J, Wright T, et al. Relation of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome. J Infect Dis 2001;184: 606-9.
8. Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-6.
9. Brown DH, Lafuse WP, Zwilling BS. Host resistance to mycobacteria is compromised by activation of the hypothalamic-pituitary-adrenal axis. Ann N Y Acad Sci 1998;840:773-86.
10. Wheeler JG, Sethi D, Cowden JM, et al. Study of infectious intestinal disease in England: Rates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive. Br Med J 1999;318:1046-50.
11. Parry S, Stansfield R, Jelley D et al. Is irritable bowel syndrome (IBS) more common in patients presenting with bacterial gastroenteritis? A community-based case-control study. Am J Gastroenterol 2003;98:327-31.
12. Ruigomez A, Wallander MA, Johansson S, Garcia Rodriguez LA. One-year follow-up of newly diagnosed irritable bowel syndrome patients. Aliment Pharmacol Ther 1999;13:1097-102.
13. Whitehead WE, Crowell MD, Heller BR, et al. Modeling and reinforcement of the sick role during childhood predicts adult illness behavior. Psychosom Med 1994;56:541-50.
14. Whitehead WE, Winget C, Fedoravicius AS, et al. Learned illness behavior in patients with irritable bowel syndrome and peptic ulcer. Dig Dis Sci 1982;27:202-8.
15. Heaton KW, Ghosh S, Braddon FEM. How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. Gut 1991;32:73-9.
16. Talley NJ, Boyce PM, Jones M. Predictors of health care seeking for irritable bowel syndrome: A population based study. Gut 1997;41:394-8.
17. Drossman DA, McKee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988;95:701-8.
18. Walker EA, Katon WJ, Jemelka RP, Roy-Byme PP. Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiologic Catchment Area (ECA) Study. Am J Med 1992;92:26S-30S.
19. Walker EA, Roy-Byme PP, Katon WJ, et al. Psychiatric illness and irritable bowel syndrome: A comparison with inflammatory bowel disease (see comments). Am J Psych 1990;147: 1656-61.
20. Herschbach P, Henrich G, von Rad M. Psychological factors in functional gastrointestinal disorders: Characteristics of the disorder or of the illness behavior? Psychosom Med 1999;61: 148-53.
21. Sandler RS, Drossman DA, Nathan HP, McKee DC. Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology 1984;87:314-8.
22. Wood GM, Gearty JC, Cooper BT. Small bowel morphology in British Indian and Afro-Caribbean subjects: Evidence of tropical enteropathy. Gut 1991;32:256-9.
23. Stewart GT. Post-dysenteric colitis. Br Med J 1950;i:405-9.
24. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47: 804-11.
25. Chan J, Gonsalkorale WM, Perrey C, et al. IL-10 and TGF-B genotypes in irritable bowel syndrome: Evidence to support an inflammatory component? Gastroenterology 2000;118:A184 (abstract).
26. MacDonald TT, Spencer J. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J Exp Med 1988;167:1341-9.
27. Carroccio A, Cavataio F, Montalto G, et al. Treatment of giardiasis reverses "active" coeliac disease to "latent" coeliac disease. Eur J Gastroenterol Hepatol 2001;13:1101-5.
28. Longstreth GF, Hawkey CJ, Mayer EA, et al. Characteristics of patients with irritable bowel syndrome recruited from three sources: Implications for clinical trials. Aliment Pharmacol Ther 2001;15:959-64.
29. Dunlop SP, Jenkins D, Spiller RC. Distinctive histological patterns of chronic inflammatory cells in rectal biopsies of patients with different clinical subtypes of IBS. Gastroenterology 2002;122A (abstract).
30. Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002;122:1778-83.